NCT05763290 Childhood Cancer Survivors' Affective Response to Exercise
| NCT ID | NCT05763290 |
| Status | Recruiting |
| Phase | — |
| Sponsor | St. Jude Children's Research Hospital |
| Condition | ALL, Childhood |
| Study Type | OBSERVATIONAL |
| Enrollment | 125 participants |
| Start Date | 2023-03-22 |
| Primary Completion | 2027-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 125 participants in total. It began in 2023-03-22 with a primary completion date of 2027-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary objective of this study is to assess the feasibility of administering the Personalized Single-Category Implicit Association Test (PSC-IAT) to young adult survivors of childhood cancer. Participants will perform a total of three trials of a cognitive task before and after their scheduled SJLIFE cardiovascular stress testing. Participants will then be asked to participate in a qualitative interview about the cognitive task tool and body sensations and emotions experienced during exercise.
Eligibility Criteria
Inclusion Criteria: * Participants enrolled in St. Jude Lifetime Cohort (SJLIFE) aged 18-39 years at completion of on campus visit * Primary diagnosis of acute lymphoblastic leukemia (ALL) * No cranial radiation therapy (CRT) as part of treatment for ALL * Identify as physically inactive (do not meet Centers for Disease Control and Prevention (CDC) guidelines of 150 minutes of moderate physical activity per week or 75 minutes of vigorous physical activity per week) * Women who are not currently pregnant Exclusion Criteria: * Individuals who cannot speak, read, and/or understand English. * Individuals with an estimated IQ of \<70 and/or per PI discretion * Individuals with any contraindication to stress testing (i.e. cardiovascular complications) * Women who are currently pregnant
Contact & Investigator
Megan Ware, MS, PhD
PRINCIPAL INVESTIGATOR
St. Jude Children's Research Hospital
Frequently Asked Questions
Who can join the NCT05763290 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 39 Years, studying ALL, Childhood. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05763290 currently recruiting?
Yes, NCT05763290 is actively recruiting participants. Contact the research team at referralinfo@stjude.org for enrollment information.
Where is the NCT05763290 trial being conducted?
This trial is being conducted at Memphis, United States.
Who is sponsoring the NCT05763290 clinical trial?
NCT05763290 is sponsored by St. Jude Children's Research Hospital. The principal investigator is Megan Ware, MS, PhD at St. Jude Children's Research Hospital. The trial plans to enroll 125 participants.